Search Results - "García Del Barrio, MA"

4CPS-165 Adaptation of marketed parenteral nutrition to the needs of a hospital by Fraile Rodriguez, C, González Martínez, S, De Amuriza Chicharro, N, Bartolome García, E, Delgado Latorre, A, García Del Barrio, MA

“…Background and ImportanceMore and more hospitals are using commercially available parenteral nutrition for their patients, and there is an increasing supply to…”
Get full text

4CPS-100 Anthracycline dosing in obese adult patients: a systematic review by Tapia, B, Casas, A, Torroba, B, Fraile, C, Gutierrez, A, Fernandez, B, Serrano-Alonso, M, García Del Barrio, MA

“…Background and importanceChemotherapy dosing for obese patients (body mass index (BMI) ≥30 kg/m2) remains undefined. Most recent publications discourage…”
Get full text

4CPS-116 Alectinib hepatic-tolerance in patients with hepatotoxicity background with other anaplastic lymphoma kinase (alk)-inhibitors by Grijalba, AI Idoate, Alvarez, E Castañon, Gomez-Acebo, B Sangro, Bazo, I Gil, Barrio, MA Garcia del

“…BackgroundALK-inhibitors are indicated in adult patients with ALK-positive advanced NSCLC, with crizotinib being the first choice. Hepatotoxicity has been…”
Get full text

Successful desensitization to oxaliplatin after a single initial dose of omalizumab in a patient with elevated IgE levels by Penella, J, Quan, P, Carvallo, A, Chopitea, A, Sala, P, García Del Barrio, M A, Gastaminza, G, Goikoetxea, M J

“…Omalizumab, an anti-IgE monoclonal antibody, is used as an adjuvant in hymenoptera venom immunotherapy and in induction of oral tolerance in food allergy. In…”
Get full text

5PSQ-060 An acute and severe event in a patient treated with ramucirumab by Irigoyen, I, Javier, I, Fuente, A de la, Chopitea, A, García-del-Barrio, MA

“…BackgroundThe cardiotoxicity of ramucirumab is still insufficiently known. Careful cardiovascular evaluation should be recommended prior to and during…”
Get full text

4CPS-114 Dosing of platinum and taxanes in obese patients: a systematic review by Casas, A, Torroba, B, Tapia, B, Garcia-Del-Barrio, MA

“…BackgroundPlatinum and taxane-based chemotherapy dosing, as in other anticancer agents, is based on body surface area, except in the case of carboplatin that…”
Get full text

4CPS-084 Anthracycline dosage in paediatric obese patients by Fernandez Garcia, B, Fraile Rodriguez, C, Abasolo Tamayo, X, Herrero Corell, I, Serrano Alonso, M, García-Del-Barrio, MÁ

“…Background and importanceIn 2016, the World Health Organization estimated that 41 million children aged <5 years were overweight. Clinicians are increasingly…”
Get full text